Home › Trial NCT07441291
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
- Trial IDNCT07441291
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorPeking University People's Hospital
- Enrollment70
- Start date2025-11-30
- ConditionsB ALL · Allogenetic Hematopoietic Stem Cell Transplantation · MRD-positive
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.